valdecoxib + valdecoxib/placebo + placebo

Phase 3Completed
0 watching 0 views this week๐Ÿ“ˆ Rising
76
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pain, Post-surgical

Conditions

Pain, Post-surgical

Trial Timeline

Dec 1, 2002 โ†’ Mar 1, 2003

About valdecoxib + valdecoxib/placebo + placebo

valdecoxib + valdecoxib/placebo + placebo is a phase 3 stage product being developed by Pfizer for Pain, Post-surgical. The current trial status is completed. This product is registered under clinical trial identifier NCT00653354. Target conditions include Pain, Post-surgical.

Hype Score Breakdown

Clinical
27
Activity
18
Company
9
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00653354Phase 3Completed